CEO of EagleImmune, Inc.
11361 Bishops Gate Ln
Laurel, MD 20723
Phone: 724-759-3066 (Cell)
Accomplished and board certified toxicologist at the FDA (former FDA officer) performed regulatory consulting and research, focusing on the evaluation of toxicological adverse events and biocompatibility of regulated products; conducting innovative research such as biomarker discovery and development through collaboration with internal and external scientists, specifically for allergic risks assessment comprised of two-arm approaches, in vitro and in silico, and that of clinical monitoring for applications in both premarket and post market; the effort is also intended to overcome the limitations of animal based tests toward the improvement of regulatory and clinical decision-making. As an effective Biocompatibility Standard Working Group member, Dr. Mu participated regulatory standard/guidance development with providing a broad array of knowledge in toxicology, biocompatibility, biomarkers, immunology, biomaterials, orthopedics, stem cell, tissue engineering, molecular biology, pre-market risk assessment and post-market safety evaluation, regulatory review process and the politics. Multilingual: Chinese, Japanese and English.
The founder of EagleImmune, started up in Maryland in June 2017.